Skip to main content
SpringerLink
Log in

Cardiovascular System

  • Chapter
Pediatric Oncology Nursing

Part of the book series: Pediatric Oncology ((PEDIATRICO,volume 22))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baglin T, Harper P, Marcus R, (1990) Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rtPA). Bone Marrow Transplantation 5(3):439–441

    PubMed  Google Scholar 

  • Bearman SI, Appelbaum FR, Buckner CD, Petersen FB Fisher LD, Clift RA, Thomas ED (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology 6(10):1562–1568

    PubMed  Google Scholar 

  • Bu Lock FA, Mott MG, Oajhill A, Martin RP (1996) Early identification of anthracycline cardiomyopathy: possibilities and implications. Archives of Disease in Childhood 75(5):416–422

    PubMed  Google Scholar 

  • Cancer Therapy Evaluation Program (2003) Common Terminology Criteria for Adverse Events, Version 3.0.DCTD, NCI, NIH, DHHS March 31, 2003. http://ctep.cancer.gov June 10

    Google Scholar 

  • Grenier MA, Lipshultz SE (1998) Epidemiology of anthracycline cardiotoxicity in children and adults. Seminars in Oncology 25(4 Supp 10):72–85

    PubMed  Google Scholar 

  • Hrstkova H, Brazdova Z, Novotny J, Bajer M (2001) Nutrition and exercise in the lifestyle of long-term survivors of childhood cancer. Scripta Medica Facultatis Medicae Universitatis Bruensis Masarykianae 74(6):379–390

    Google Scholar 

  • Iarussi D, Indol. P, Galderisi M, Bossone E (2000) Cardiac toxicity after anthracycline chemotherapy in childhood. Herz 25(7):676–688

    PubMed  Google Scholar 

  • Jensen BV, Neilson SL, Skovsgaard T (1996) Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy. Lancet 347(8997):297–299

    PubMed  Google Scholar 

  • Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA (2002) Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systemic review. Annals of Oncology 13(6):819–829

    PubMed  Google Scholar 

  • Langebrake C, Reinhardt D, Ritter J (2002) Minimising the long-term adverse effects of childhood leukaemia therapy. Drug Safety 25(15):1057–1077

    PubMed  Google Scholar 

  • Lanzarini L, Bossi G, Laudisa ML, Klersy C, Arico M (2000) Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines. American Heart Journal 140(2):315–323

    PubMed  Google Scholar 

  • Lanzkowsky, P (1999) Manual of Pediatric Hematology, 3rd edn. London, Academic Press

    Google Scholar 

  • Levitt G, Bunch K, Rogers CA, Whitehead B (1996) Cardiac transplantation in childhood cancer survivors in Great Britain. European Journal of Cancer 32A(5):826–830

    PubMed  Google Scholar 

  • Lipshultz SE, Giantris AL, Lipshultz SR, Kimball Dalton V, Asselin BL, Barr RD, et al. (2002) Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 acute lymphoblastic leukemia protocol. Journal of Clinical Oncology 20(6):1677–82

    PubMed  Google Scholar 

  • Lopez M (1999) Dexrazoxane. Current status and prospectives of cardiotoxicity of chemotherapy. Clinica Terapeutica 150(1):37–49

    PubMed  Google Scholar 

  • Oeffinger KC, Buchanan GR, Eshelman DA, Denke MA, Andrews C, Germak JA, Tomlinson GE, Snell LE, Foster BM (2001) Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology 23(7):424–430

    PubMed  Google Scholar 

  • Ortega JA, Donaldson SS, Ivy SP, Pappo A, Maurer HM (1997) Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group, Children’s Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Centre Cancer 70(12):2435–2439

    Google Scholar 

  • Reiss U, Cowan M, McMillan A & Horn B, (2002) Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors and outcome in a cohort of 241 patients. Journal of Pediatric Hematology and Oncology 24(9):746–750

    Google Scholar 

  • Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, Kinchla NM, Neuberg D, Waller EK, Antin JH, Soiffer R, Vredenburgh J. Lill M. Woolfrey AE, Bearman SI, Iacobelli M, Fareed J, Guinan EC (1998) Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in high-risk population. Blood 92(3):737–744

    PubMed  Google Scholar 

  • Speyer J, Wasserheit C (1998) Strategies for reduction of anthracycline cardiac toxicity. Seminars in Oncology 25(5):525–537

    PubMed  Google Scholar 

  • Trobaugh-Lotrarion A, Greffe B, Deterding R, Deutsch G, Quinones R (2003) Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage iv neuroblastoma: case report and literature review. Journal of Pediatric Hematology and Oncology 25(5):405–409

    Google Scholar 

  • Vogelsang G B, Dalal J (2002) Hepatic venoocclusive disease in blood and bone marrow transplantation in children: incidence, risk factors and outcome. Journal of Pediatric Hematology and Oncology 24(9):706–709

    Google Scholar 

  • Evans M, Gibson F (1999) Paediatric Oncology: Acute Nursing Care. London, Whurr

    Google Scholar 

  • Lilleyman J, Hann I, Blanchette V, (2000) Pediatric Hematology, 2nd edn. Edinburgh, Churchill Livingston

    Google Scholar 

Download references

Authors
  1. Ali Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Nursing Studies, University of Edinburgh, 31 Buccleuch Place, Edinburgh, EH8 9JT, Scotland, UK

    Deborah Tomlinson MN, RSCN, RGN (Dip. Cancer Nursing Macmillan Lecturer/Project Leader) (Dip. Cancer Nursing Macmillan Lecturer/Project Leader)

  2. Center for Innovation and Clinical Scholarship, Children’s Hospital Boston, Wolbach 201 300 Longwood Avenue, Boston, MA, 02115, USA

    Nancy E. Kline PhD, RN, CPNP, FAAN (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hall, A. (2005). Cardiovascular System. In: Tomlinson, D., Kline, N.E. (eds) Pediatric Oncology Nursing. Pediatric Oncology, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26784-0_19

Download citation

  • DOI: https://doi.org/10.1007/3-540-26784-0_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40851-2

  • Online ISBN: 978-3-540-26784-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation